Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IGL Group, also known as Institut Georges Lopez, is a prominent medical technology company specializing in the field of organ transplantation and preservation. The company develops, manufactures, and markets a comprehensive range of medical devices and preservation solutions designed to maintain organ viability from procurement to transplantation. Its flagship product, IGL-1, is a widely recognized preservation solution for abdominal organs, while the acquisition of the Celsior brand expanded its reach into cardiothoracic preservation. Headquartered in France, IGL Group operates globally, providing critical tools to transplant centers to reduce ischemia-reperfusion injury and improve patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IGL Group.